EBV Antibody in Sera of Non-human Primates

Abstract

SEVERAL investigators have assayed sera of non-human primates for antibody to the Epstein–Barr virus (EBV). Gerber and Birch¹ reported the widespread distribution of complement-fixing antibody derived from the chimpanzee, baboon, rhesus and African green monkey. In a subsequent study, Gerber and Rosenblum² reported that many rhesus monkeys bled within 4 days of capture were also EBV seropositive, but Henle and Henle³ had previously failed to demonstrate EBV antibody using the indirect immunofluorescence method in sera from the chimpanzee, baboon and rhesus monkey. Two of 4 baboons, however, inoculated in our laboratory with 10⁸ EB3 cells were found by the Henles³ to have low levels of antibody 4–8 weeks after exposure. Landon and Malan⁴ have reported the presence of EBV antibody in rhesus and cynomolgus monkeys at birth. This antibody disappeared after 8–10 months, although sera from the mothers of these animals remained positive. Levy et al.⁵ were able to demonstrate antibody in 2 of 3 chimpanzees bled immediately after capture in the jungle. The number of animals used, species and geographic distribution, and finally the lack of history on the animals involved in all of these studies, plus the need for a suitable experimental host system, suggested that additional studies were worth pursuing.